The title caught my eye walking through my local drugstore. AD is starting to gain more traction that the roots of the disease start with inflammation rather than plaques and tangles. #alzheimers #inflammation #neuroinflammation
INmune Bio Inc.
Biotechnology Research
Boca Raton, Florida 3,617 followers
INmune Bio is focused on modulating components of the innate immune system to activate an immune response to diseases.
About us
INmune Bio Inc. is a clinical stage immuno-oncology company focused on harnessing the patient’s immune system to treat cancer. INKmune, the company’s lead product, primes patient’s NK cells (natural killer cells) to kill cancer. INmune is targeting residual disease, the cancer cells that survive initial treatments that return to cause the cancer relapse. By controlling residual disease, patients may live longer. Using a novel mechanism of action and a precision medicine approach, INKmune therapy should enhance NK cells’ ability to eliminate residual disease. Media coverage provided for informational purposes only and third party links provided as a resource. INmune Bio does not control the content of third parties. XPro1595, Quellor, LIVNate, INB03, INKmune and other drug candidates, have not yet been shown to be safe or effective, and has not been approved by any regulatory body.
- Website
-
http://www.inmunebio.com
External link for INmune Bio Inc.
- Industry
- Biotechnology Research
- Company size
- 11-50 employees
- Headquarters
- Boca Raton, Florida
- Type
- Privately Held
Locations
-
Primary
Get directions
255 NE Mizner B
Suite 640
Boca Raton, Florida 33432, US
Employees at INmune Bio Inc.
Updates
-
Join INmune Bio Inc. (#INMB) for a virtual KOL event on Thurs, Nov. 7 at 1pm ET featuring Prof. Judith Jaeger, PhD, MPA and Sarah Barnum, PhD, ABPP from CognitionMetrics who will join Christopher (CJ) Barnum PhD, PhD, VP of CNS Drug Development, to discuss the unmet need and current treatment landscape for patients with Early Alzheimer’s Disease (AD) with biomarkers of elevated neuroinflammation. Register here: https://lnkd.in/gkPWhcdh
-
-
Key Points from the article: "Inflammaging, a chronic low-grade inflammation, is associated with an increased risk of heart attack, cancer, Alzheimer's and other conditions. It occurs as we age, but some people develop it more than others. Chronic inflammation can be caused by cellular senescence, where damaged aging cells secrete inflammatory proteins. Prevention and treatment measures include lifestyle changes such as exercise, healthy diet and adequate sleep."